Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.

Ann Allergy Asthma Immunol

Division of Immunology and Allergy, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

Published: July 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931721PMC
http://dx.doi.org/10.1016/j.anai.2016.03.022DOI Listing

Publication Analysis

Top Keywords

treatment moderate
4
moderate severe
4
severe pediatric
4
pediatric asthma
4
asthma omalizumab
4
omalizumab potential
4
potential future
4
future monoclonal
4
monoclonal antibodies
4
treatment
1

Similar Publications

Diagnostic and Therapeutic Approach to Rare Tongue Lipoma.

J Craniofac Surg

October 2024

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University.

Lipomas are benign soft tissue tumors composed of mature adipocytes, commonly found in subcutaneous tissues. Despite their prevalence in various body regions, they are relatively rare in the oral and maxillofacial regions. This study retrospectively analyzed the clinical and imaging characteristics, as well as the treatment outcomes of 57 patients diagnosed with lipoma.

View Article and Find Full Text PDF

Background And Objectives: The Chordate System administers kinetic oscillation stimulation (K.O.S) into the nasal cavity thereby potentially modulating the activity of trigemino-autonomic reflex.

View Article and Find Full Text PDF

Objective: To evaluate the feasibility of the International Caries Classification and Management System (ICCMS) protocol in a hospital-based setting in India.

Methods: A total of 160 children, 3-6 years old children reporting with dental caries to a hospital-based setting were recruited. Risk-based management of dental caries was conducted and followed for one year as per the modified ICCMS protocol.

View Article and Find Full Text PDF

Objectives: Ulcerative colitis (UC) is characterized by colonic inflammation, with neutrophils playing a key role in UC activity, prognosis, and response to therapies. Current UC therapeutics can have significant side effects and limited efficacy. ADS051 is a novel, oral, gut-restricted small molecule that modulates neutrophil migration and activation without in vitro suppression of T-cell activation.

View Article and Find Full Text PDF

Objective: To examine the evidence addressing the management of X-linked hypophosphatemia (XLH) in children to inform treatment recommendations.

Methods: We searched Embase, MEDLINE, Web of Science, and Cochrane Central up to May 2023. Eligible studies included RCTs and observational studies of individuals less than 18yrs with clinically or genetically confirmed XLH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!